Literature DB >> 1607711

Human immunodeficiency virus type 1 infection in women attending a sexually transmitted diseases clinic in Kenya.

P J Plourde1, F A Plummer, J Pepin, E Agoki, G Moss, J Ombette, A R Ronald, M Cheang, L D'Costa, J O Ndinya-Achola.   

Abstract

A cross-sectional study was conducted among women attending a sexually transmitted diseases clinic in Nairobi, kenya, to determine the prevalence of and associated risk factors for human immunodeficiency virus (HIV) type 1 infection. HIV-1 antibody was detected in 13.8% of 600 women. This virus was found most frequently in prostitutes (odds ratio [OR], 7.2), in women reporting a history of genital ulcers (OR, 2.3), and in those with a current diagnosis of genital ulcers (OR, 5.1). Lifetime duration of oral contraceptive use was significantly greater in HIV-1-positive women. Multivariate analysis revealed an association between genital ulcers and HIV-1 infection (OR, 3.8). The strongest association for HIV-1 infection, however, occurred with genital ulcers in combination with the use of oral contraceptives (OR, 25.7).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1607711     DOI: 10.1093/infdis/166.1.86

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

Review 1.  Barrier methods of contraception, spermicides, and sexually transmitted diseases: a review.

Authors:  L C d'Oro; F Parazzini; L Naldi; C La Vecchia
Journal:  Genitourin Med       Date:  1994-12

2.  Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling.

Authors:  Charles S Morrison; Pai-Lien Chen; Cynthia Kwok; Barbra A Richardson; Tsungai Chipato; Roy Mugerwa; Josaphat Byamugisha; Nancy Padian; David D Celentano; Robert A Salata
Journal:  AIDS       Date:  2010-07-17       Impact factor: 4.177

3.  Should screening of genital infections be part of antenatal care in areas of high HIV prevalence? A prospective cohort study from Kigali, Rwanda, 1992-1993. The Pregnancy and HIV (EGE) Group.

Authors:  V Leroy; A De Clercq; J Ladner; J Bogaerts; P Van de Perre; F Dabis
Journal:  Genitourin Med       Date:  1995-08

Review 4.  Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

Authors:  Zdenek Hel; Elizabeth Stringer; Jiri Mestecky
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

Review 5.  Contraceptive methods and the transmission of HIV: implications for family planning.

Authors:  C C Daly; G E Helling-Giese; J K Mati; D J Hunter
Journal:  Genitourin Med       Date:  1994-04

6.  Risk profiles for genital infection in women.

Authors:  B A Evans; T Tasker; K D MacRae
Journal:  Genitourin Med       Date:  1993-08

7.  Inducible immunity with a pilus preparation booster vaccination in an animal model of Haemophilus ducreyi infection and disease.

Authors:  M Desjardins; L G Filion; S Robertson; D W Cameron
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

8.  Evaluation of humoral and cell-mediated inducible immunity to Haemophilus ducreyi in an animal model of chancroid.

Authors:  M Desjardins; L G Filion; S Robertson; L Kobylinski; D W Cameron
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

9.  Sexual risk factors for HIV infection in early and advanced HIV epidemics in sub-Saharan Africa: systematic overview of 68 epidemiological studies.

Authors:  Li Chen; Prabhat Jha; Bridget Stirling; Sema K Sgaier; Tina Daid; Rupert Kaul; Nico Nagelkerke
Journal:  PLoS One       Date:  2007-10-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.